No Detail Found!

Association of Non-alcoholic Fatty Liver Disease with Serum Uric Acid.

Author(s)
Sarwat Abbasi Department of Biochemistry, Ayub Medical College, Abbottabad, Pakistan
Nadia Haleem Department of Surgery, Ayub Medical College Abbottabad, Pakistan
Sara Jadoon Department of Surgery, Ayub Medical College Abbottabad, Pakistan
Amjad Farooq Department of Surgery, Ayub Medical College Abbottabad, Pakistan
Abstract
Background: Non-alcoholic fatty liver disorder is a clinicopathological condition, characterized by macro vesicular steatosis in hepatic cells and metabolic stress related disorders without other causes of chronic hepatic disease. Uric acid is basically a heterocyclic compound of hydrogen, carbon, oxygen and nitrogen. Uric acid is the metabolic end product of purine metabolism. Hyperuricemia is considered to be related with the causes responsible for the production of metabolic syndrome. It may cause gout, impaired renal function, hypertension, hypertriglyceridemia, obesity and diabetes mellitus. The objective of study is to investigate the association of non-alcoholic fatty liver disease (NAFLD) and serum uric acid level. METHODS: This cross-sectional study was conducted at Ayub Teaching institute Abbottabad. According to predesigned questionnaire and informed consent, 100 subjects between ages 40-50 years were selected for the study. Data collected and analysis done by SPSS version 20. RESULTS: It was observed that 20 (40%) subjects developed NAFLD as compared to 30(60%) of the subjects with normal serum uric acid level. Chi-square test was applied and values found to be significant (p=0.013). CONCLUSION: Our study shows association of NAFLD with serum uric acid level.
Publication Details
Page(s) 64-66
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 31, Issue: 1, Year: 2019

Request the full text from PASTIC

References
BarshopNJ,SirlinCB,SchwimmerJB,LavineJE, 2008.Review article: epidemiology, pathogenesis and potential treatments of paediatric nonalcoholic fatty liver disease,Aliment Pharmacol Ther 28 13 -24
FanJG,FarrellGC, 2009.Epidemiology of non-alcoholic fatty liver disease in China,J Hepatol 50 204 -210
AmarapurkarDN,HashimotoE,LesmanaLA,SollanoJD,ChenPJ,GohKL, 2007.How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol, 22 788 -793
FracanzaniAL,ValentiL,BugianesiE,AndreolettiM,ColliA,VanniE, 2008.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase Levels: A role for insulin resistance and diabetes,Hepatology 48 792 -798
Neuschwander-TetriBA,CaldwellSH, 2003.Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, 37 1202 -1219
MarchesiniG,BriziM,BianchiG,TomassettiS,BugianesiE, 2001.Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,Diabetes 50 1844 -1850
MarchesiniG,BugianesiE,ForlaniG,CerrelliF,LenziM, 2003.Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome,Hepatology 37 917 -923
YooTW,SungKC,ShinHS,KimBJ,KimBS, 2005.Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome,Circ J 69 928 -933
HjortnaesJ,AlgraA,OlijhoekJ,HuismanM,JacobsJ,ChoiHK,FordES, 2007.Prevalence of the metabolic syndrome in individuals with hyperuricemia,Am J Med 120 442 -447
2018.,Accepted: 3 October -
LiY,XuC,YuC, 2009.Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study,J Hepatol 50 1029 -34
HaqA,MahmoodR,AhmadZ,RehmanJ,JilaniG, 2010.Association of serum uric acid with blood urea and serum creatinine,Pak J Physiol 6 -
SafiAJ,MahmoodR,KhanMA,Haq, 2004.AU.Association of Serum Uric Acid with type 2 Diabetes Mellitus,J Pak Med Ins. -
HaydenMR,TyagiSC, 2004.Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle,Nutr Metab (Lond) 1 10 -
Harrison R,BerryCE,HareJM,BaskolG,BaskolM,KocerD, 2007.Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis,Clin Biochem 40 776 -780
De OliveiraEP,BuriniRC, 2012.High plasma uric acid concentration: causes and consequences,Diabetol Metab Syndr 4 12 -
PettaS,CammaC,CabibiD,Di MarcoV,CraxiA, 2011.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease,Aliment Pharmacol Ther 34 757 -766
KonoH,ChenCJ,OntiverosF,RockKL, 2010.Uric acid promotes an acute inflammatory response to sterile cell death in mice,J Clin Invest 120 1939 -1949
HoqueR,VodovotzY,MehalW, 2013.Therapeutic strategies in inflammasome mediated diseases of the liver,J Hepatol 58 1047 -1052
Shi Y, 2010.Caught red-handed: uric acid is an agent of inflammation,J Clin Invest 120 1809 -1811
MarangellaM., 2005.Uric acid elimination in the urine, -
.Pathophysiological implications,Contrib Nephrol 147 132 -48
BaldwinW,McRaeS,MarekG, 2011.Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome,Diabetes 60 1258 -69
SautinYY,NakagawaT,ZharikovS,KangDH,HanL,OuyangX, 2005.Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter,Am J Nephrol 25 425 -33
KanellisJ,WatanabeS,LiJH, 2003.Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2, 41 1287 -93
DasarathyS,DasarathyJ,KhiyamiA, 2009.Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study,J Hepatol 51 1061 -7
LanaspaMA,TapiaE,SotoV, 2011.Uric acid and fructose: potential biological mechanisms,Semin Nephrol 31 426 -32
LimJS,Mietus-SnyderM,ValenteA, 2010.The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome,Nat Rev Gastroenterol Hepatol 7 251 -64
0

Citations

0

Downloads

58

Views